CLINICAL_TRIALS trial_result · 2026-07-10

Clinical Trial Results: A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD) [Phase 3]

Phase 3 trial evaluating REL-1017 as adjunctive treatment for major depressive disorder has terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Levomecor Inc. | Conditions: Major Depressive Disorder, Depression | Phase 3 | Status: TERMINATED | Results posted: 2026-07-10